intellectual disability, autosomal recessive 18

Rare Disease

MONDO:0013651

Also known as:

MED23 autosomal recessive non-syndromic intellectual disabilityautosomal recessive non-syndromic intellectual disability caused by mutation in MED23intellectual developmental disorder, autosomal recessive 18, with or without epilepsy

Any autosomal recessive non-syndromic intellectual disability in which the cause of the disease is a mutation in the MED23 gene.

Genes

Clinical Trials

–

Newborn Screening

–

Patient Groups

–

Patient-Friendly Information

Comprehensive, easy-to-understand information about this condition

How we create this content →

Report Generation Failed

We couldn't automatically generate the report. This may be due to temporary service issues.

Companies Active in intellectual disability, autosomal recessive 18

0 approved

Organizations with approved therapies for this disease

No approved therapies yet

Research is ongoing — 1 company has orphan drug designations for this disease

Vanda Pharmaceuticals Inc.

Other

Designated

View all companies active in intellectual disability, autosomal recessive 18

Need this data in your product?

Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.

Explore API Start Free

← Back to All Diseases